HOME >> MEDICINE >> NEWS
Many postmenopausal women with cardiovascular disease don't use lifesaving aspirin therapy

ORLANDO, Feb.18 Low-dose aspirin therapy has been shown to reduce the chances of a secondary heart attack or stroke in women who already have cardiovascular disease (CVD). Yet, less than half of women with CVD use this over-the-counter, relatively inexpensive therapy, researchers reported today at the Second International Conference on Women, Heart Disease and Stroke.

"We know that aspirin therapy helps women who have cardiovascular disease live longer and feel better. Our study sought to characterize the extent to which women use this easily accessible therapy, as well as the disparities that exist between different groups of women," said lead author Jeffrey S. Berger, M.D., chief resident at Beth Israel Medical Center in New York.

Berger and colleagues examined data from the Women's Health Initiative Observational Study, which tracked nearly 100,000 post-menopausal women. The researchers singled out 8,928 women in the study who had a history of cardiovascular disease, including stroke and heart attack. The women had reported if they were on aspirin and other therapies.

Studies have shown that about 95 percent of the women who have cardiovascular disease should be taking aspirin, as well as other medications, to help ward off secondary heart attacks and strokes. Less than 5 percent of women with CVD might not be eligible for aspirin therapy because of side effects, such as bleeding, Berger said.

The researchers found that 4,101 (46 percent) of the women with CVD were on low-dose aspirin therapy. Only 43 percent of women with prior stroke were on aspirin therapy. And among the 2,230 patients with documented heart attacks, only 54 percent reported using aspirin.

"Ideally, the percentage of women with a known history of cardiovascular disease who take aspirin should be above 90. To find such low numbers was quite discouraging," Berger said.

Looking at the data in more detail, the researchers found that women with existing CVD
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
18-Feb-2005


Page: 1 2

Related medicine news :

1. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women
2. Abdominal fat indicates severity of metabolic syndrome in obese, postmenopausal women
3. Hormone therapy may still offer important health benefits to postmenopausal women
4. New research on reduced bone mass and risk of fracture in postmenopausal women
5. Research in monkeys suggests estrogen therapy may lower androgens in postmenopausal women
6. Untreated postmenopausal women with osteoporosis
7. Estrogenlike drugs may eventually help postmenopausal women with weight gain
8. Estrogen offers no overall benefit for disease prevention in postmenopausal women with hysterectomy
9. Study finds fewer, but more advanced, colon cancers in postmenopausal women on E&P hormone therapy
10. Estrogren plus progestin decreases colorectal cancer in postmenopausal woman
11. New study details effects of exercise on sleep quality in postmenopausal women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... ... ... ProRehab Louisville and Dr. Stacie Grossfeld have partnered with Louisville Skating Academy (LSA) ... medical care and sport injury experts for rehabilitation. , “It is vital to ... individualized treatment plan, and understands what a triple toe loop is in order to ...
(Date:8/19/2019)... Calif. (PRWEB) , ... August 19, 2019 , ... A ... suggests that dog owners should be brushing their pets’ teeth twice a day. The ... not have the time and suggests that close monitoring and brushing at least twice ...
(Date:8/19/2019)... ... August 18, 2019 , ... ... launches its third product, Aqua+, adding two SKUs to its line of functional ... and more effectively than water alone. Distinguishing Aqua+ from other rehydration solutions is ...
(Date:8/17/2019)... ... August 17, 2019 , ... ... America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd Year In a ... Revenue Growth of 192% Percent , Inc. magazine today revealed that YellowTelescope LLC ...
(Date:8/16/2019)... (PRWEB) , ... August 16, 2019 , ... ... revolutionize and standardize pharmaceutical and non-pharmaceutical cannabidiol (CBD) products across the CBD market ... set to launch its crowdfunding campaign to raise $50 million on September 9, ...
Breaking Medicine News(10 mins):
(Date:8/21/2019)... ... August 21, 2019 , ... Impact Advisors , a ... announced today that it has been named to Inc. magazine’s Inc. 5000 list. The ... for-profit companies with significant percentage revenue growth. This year the firm was also named ...
(Date:8/19/2019)... ... August 19, 2019 , ... ... today announced the findings of research validating the clinical impact of MedAware’s machine ... published 7 August 2019 in the Journal of American Medical Informatics Association ...
(Date:8/19/2019)... ... 19, 2019 , ... The International Association of Eating Disorders ... the field of treatment for eating disorders, recommends membership for professionals who are ... a similar mission. , Founded in 1985, the iaedp™ Foundation is the ...
Breaking Medicine Technology:
Cached News: